38^th European Neurology Congress 2025 December 01-02, 2025 Vancouver, Canada

Dr. Dionisio Figueiredo Lopes is a highly distinguished neurosurgeon, recognized for his expertise, dedication, and contributions to the field of neurosurgery. With a career spanning years of clinical excellence, research, and innovation, he has established himself as a leader in the treatment of complex neurological disorders.

As the Head of Neurosurgery at Hospital Urgencia Otavio Lage, Dr. Lopes plays a pivotal role in delivering high-quality neurosurgical care while mentoring and guiding the next generation of neurosurgeons. He is also a respected consultant at leading medical institutions, where he collaborates with multidisciplinary teams to advance neurosurgical practices and improve patient outcomes.

Dr. Lopes is a member of the Brazilian Neurosurgery Society and Academy, actively contributing to the advancement of neurosurgical knowledge and techniques. His commitment to professional excellence has led him to pursue advanced training internationally, refining his skills and expertise.

Dr. Dionisio Figueiredo Lopes' research interests focus on neuro-oncology, advanced neurosurgical techniques, and minimally invasive brain surgery. He is dedicated to exploring innovative treatments and surgical advancements to improve patient outcomes in complex neurosurgical conditions.

Professor Peter Silburn AM is a world-renowned neurologist, researcher, and leader in the field of Parkinson’s disease and movement disorders. With an esteemed career dedicated to advancing neurology and pioneering new treatments for neurodegenerative diseases, he has become a global authority in the field of neuromodulation and deep brain stimulation (DBS). His work has transformed the lives of countless patients and shaped the future of medical science.

Early Life and Education

Professor Silburn’s passion for neurology was ignited during his early academic years. His journey began with a strong foundation in medicine, followed by specialized training in neurology and movement disorders. He pursued advanced studies at some of the world’s most prestigious institutions, including Oxford University and the Karolinska Institute in Sweden, where he refined his expertise in treating Parkinson’s disease and other neurodegenerative conditions.

Career and Research Contributions

Throughout his career, Professor Silburn has been at the forefront of neuromodulation research, with a particular focus on deep brain stimulation (DBS). His work has led to groundbreaking advancements in the use of DBS to treat Parkinson’s disease, dystonia, essential tremor, and other neurological disorders. As a founding member and lead clinician at the Asia-Pacific Centre for Neuromodulation (APCN), he has played a pivotal role in developing and refining surgical techniques that have significantly improved patient outcomes.

His research has not only advanced medical science but also bridged the gap between neurology, neurosurgery, and cutting-edge technology. His studies have contributed to a deeper understanding of how brain circuits can be modulated to restore movement and improve quality of life for patients suffering from debilitating disorders.

Professor Peter Silburn's research interests focus on Parkinson’s disease, neurodegenerative disorders, deep brain stimulation, and neuromodulation therapies to enhance patient outcomes.

Dr. AlKherayf is a highly skilled neurosurgeon specializing in complex spine surgery and minimally invasive skull base procedures. After completing his neurosurgery training at the University of Ottawa, he pursued advanced fellowships to refine his expertise. He also holds a Master’s in Epidemiology and completed the Clinician Investigator Program through the Royal College of Physicians and Surgeons of Canada. With a dedication to innovation and precision, Dr. AlKherayf continues to advance neurosurgical care and research.

Dr. AlKherayf's research interests include complex spine surgery, minimally invasive skull base surgery, clinical epidemiology, and advancing surgical techniques for improved patient outcomes.

A distinguished scientist and esteemed Editorial Board Member, Dr. Chethan P Venkatasubba Rao contributes to numerous peer-reviewed journals and serves as a reviewer for prestigious institutions, including the NIH, DOD, and BSF. With a keen eye for scientific excellence, Dr. [Name] has been an invited reviewer for over 30 renowned journals, playing a vital role in advancing research and innovation in the field.

Dr. Chethan P Venkatasubba Rao research interests include peer-reviewed scientific evaluation, biomedical research, and advancing innovation through critical analysis and review.

Dr. Rowell is a distinguished economist with expertise in health economics and insurance markets. Earning his PhD from the University of Queensland, his research explores moral hazard in automobile insurance and has been supported by the prestigious Brian Gray Scholarship. As a postdoctoral fellow at Griffith University and the University of Queensland, his work spans labor market outcomes for spinal cord injury patients, hospital adverse events, and the economic impact of neurosurgical interventions. His current research focuses on insurance economics, harm mitigation for problem gamblers, and the role of telehealth in primary care delivery.

Dr. Rowell's research interests include health economics, insurance markets, harm mitigation strategies, telehealth, and the economic impact of neurosurgical interventions.

Dr. Shireen Qureshi is a dedicated leader in epilepsy research and advocacy, serving as a Board Member of the Saudi Epilepsy Society and Head of its Scientific and Research Committee. Committed to advancing epilepsy care, Dr. [Name] plays a pivotal role in shaping research initiatives and promoting scientific excellence in the field.

Dr. Shireen Qureshi research interests include epilepsy, seizure management, neuromodulation, and advancing innovative treatments for epilepsy care.

Dr. Chia-Chun Chiang, M.D., is a distinguished Assistant Professor of Neurology, recognized for her dedication to advancing neurological research, patient care, and medical education. With a profound passion for innovation and an unwavering commitment to improving patient outcomes, she has emerged as a leading force in the field of neurology. Through her clinical expertise, pioneering research, and dedication to mentoring future neurologists, she continues to shape the future of neurological science.

Early Education and Medical Training

Dr. Chiang’s journey into the world of neurology was fueled by a deep curiosity about the complexities of the human brain and a desire to improve the lives of those affected by neurological disorders. Her extensive medical training provided her with a strong foundation in diagnosing and treating a wide range of neurological conditions. Through years of rigorous study, specialized training, and hands-on experience, she honed her skills, positioning herself as an expert in the field.

Clinical Excellence and Patient-Centered Care

As a practicing neurologist, Dr. Chiang is deeply committed to providing comprehensive, patient-centered care. Her clinical approach combines the latest advancements in medical research with a compassionate, individualized treatment strategy. She specializes in diagnosing and managing complex neurological disorders, ensuring that her patients receive the most effective, cutting-edge treatments available.

Her ability to blend scientific knowledge with a human-centered approach has made her a trusted and respected figure among both patients and colleagues. She believes that behind every diagnosis is a unique individual, and she is dedicated to helping each patient regain the best possible quality of life.

Dr. Chia-Chun Chiang , M.D. research interests include neurological disorders, neurodegenerative diseases, and innovative treatments in neurology.

With over 25 years of expertise in preparative chromatography, Olivier has established himself as a pioneer in advanced separation technologies, revolutionizing the field with his contributions to continuous processing, simulated moving bed (SMB) technology, flow chemistry, and cutting-edge chromatographic solutions. His work has been instrumental in shaping the future of industrial separations, enabling more efficient and sustainable processes across various industries.

Early Career and Pioneering Work in SMB Technology

Olivier’s journey in chromatography began with a deep passion for precision separation science. His early career saw him play a pivotal role in the development and commercialization of SMB technology at Prochrom in France, a groundbreaking advancement in the field of continuous chromatography. His expertise in chiral separations further expanded at Chiral Technologies Europe, where he managed SMB-based chiral separation services, optimizing enantioselective purifications for the pharmaceutical and fine chemical industries.

These early experiences solidified his reputation as an innovator, setting the foundation for his future leadership in chromatography.

Driving Innovation at AFC

Since joining AFC (Advanced Fractionation & Chromatography) in 2001, Olivier has been at the forefront of technological advancements in continuous chromatographic processes. His leadership has been instrumental in developing next-generation separation techniques, enhancing efficiency, scalability, and sustainability in the field. His expertise spans:

• SMB (Simulated Moving Bed) Technology – Optimizing continuous chromatography for high-purity separations.
• Flow Chemistry – Integrating advanced flow-based techniques to enhance reaction efficiency.
• Innovative Separation Technologies – Pushing the boundaries of preparative chromatography with novel methodologies.

Olivier’s contributions have helped reshape industrial chromatography, offering cost-effective, high-performance solutions that are widely adopted in pharmaceuticals, specialty chemicals, and bioprocessing.

A Visionary Leader in Chromatographic Sciences

Beyond his technical expertise, Olivier is a thought leader in chromatography, continuously exploring new frontiers in separation science. His insights and innovations have accelerated the adoption of continuous processing, helping industries reduce waste, improve productivity, and achieve superior product purity.

His ability to bridge theoretical expertise with practical applications has made him a sought-after mentor, collaborator, and industry expert. His passion for chromatography extends beyond research—he is dedicated to educating and mentoring professionals, ensuring that the next generation continues to push the limits of separation science.

Olivier’s research interests include preparative chromatography, continuous processes, SMB technology, flow chemistry, and advanced separation techniques.

Professor Emeritus Walter E. Müller is a distinguished pharmacologist with a prolific career in neuropsychopharmacology. Earning his PhD from the University of Mainz, he has held esteemed positions at the University of Heidelberg and the Biocenter, University of Frankfurt. A recipient of prestigious awards, including the Fritz Külz Prize and the AGNP Psychopharmacology Award, he is also a Fellow of the American College of Neuropsychopharmacology and an Honorary Member of the Austrian Society of Biological Psychiatry. With over 500 publications and a remarkable h-index of 68, his research has profoundly impacted the field.

Professor Walter E. Müller's research interests include neuropsychopharmacology, mental health disorders, drug development, and the molecular mechanisms of psychiatric diseases.